Blp1 protein shows virulence-associated features and elicits protective immunity to Acinetobacter baumannii infection

[1]  R. Briandet,et al.  The Mutation of Conservative Asp268 Residue in the Peptidoglycan-Associated Domain of the OmpA Protein Affects Multiple Acinetobacter baumannii Virulence Characteristics , 2019, Molecules.

[2]  C. Péchoux,et al.  Surface-Related Features and Virulence Among Acinetobacter baumannii Clinical Isolates Belonging to International Clones I and II , 2019, Front. Microbiol..

[3]  E. Sundberg,et al.  The structure of PilA from Acinetobacter baumannii AB5075 suggests a mechanism for functional specialization in Acinetobacter type IV pili , 2018, The Journal of Biological Chemistry.

[4]  R. Bonomo,et al.  New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections , 2018, Antimicrobial Agents and Chemotherapy.

[5]  R. Briandet,et al.  Clostridium difficile Biofilm: Remodeling Metabolism and Cell Surface to Build a Sparse and Heterogeneously Aggregated Architecture , 2018, Front. Microbiol..

[6]  C. Colombo,et al.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development , 2018, Molecules.

[7]  Xianjun Wang,et al.  Simultaneous emergence and rapid spread of three OXA-23 producing Acinetobacter baumannii ST208 strains in intensive care units confirmed by whole genome sequencing. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[8]  M. Feldman,et al.  Uncovering the mechanisms of Acinetobacter baumannii virulence , 2017, Nature Reviews Microbiology.

[9]  I. Voets,et al.  Structure of a 1.5-MDa adhesin that binds its Antarctic bacterium to diatoms and ice , 2017, Science Advances.

[10]  A. Tsakris,et al.  Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study. , 2017, International journal of antimicrobial agents.

[11]  M. Al-agamy,et al.  The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital , 2017, Annals of Clinical Microbiology and Antimicrobials.

[12]  Z. Daoud,et al.  Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital , 2017, PloS one.

[13]  Michael Otto,et al.  Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance , 2017, Nature Reviews Drug Discovery.

[14]  K. Ko,et al.  Occurrence of Diverse AbGRI1-Type Genomic Islands in Acinetobacter baumannii Global Clone 2 Isolates from South Korea , 2016, Antimicrobial Agents and Chemotherapy.

[15]  Balamurugan Periaswamy,et al.  Point mutations in the major outer membrane protein drive hypervirulence of a rapidly expanding clone of Campylobacter jejuni , 2016, Proceedings of the National Academy of Sciences.

[16]  J. O’Gara,et al.  Untangling the Diverse and Redundant Mechanisms of Staphylococcus aureus Biofilm Formation , 2016, PLoS pathogens.

[17]  Xiaojiao Zhang,et al.  Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii. , 2016, Microbial pathogenesis.

[18]  Prince Sharma,et al.  Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine Candidate , 2016, Front. Microbiol..

[19]  Weiwei Huang,et al.  Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii , 2016, Scientific Reports.

[20]  E. De Gregorio,et al.  Biofilm-associated proteins: news from Acinetobacter , 2015, BMC Genomics.

[21]  F. Shahcheraghi,et al.  Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection. , 2015, Molecular immunology.

[22]  S. Schild,et al.  Multifaceted roles of extracellular DNA in bacterial physiology , 2015, Current Genetics.

[23]  Chul Hee Choi,et al.  Simple Method for Markerless Gene Deletion in Multidrug-Resistant Acinetobacter baumannii , 2015, Applied and Environmental Microbiology.

[24]  Karl A. Hassan,et al.  Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii , 2014, BMC Genomics.

[25]  Bin Chen,et al.  Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models , 2014, PloS one.

[26]  B. Liu,et al.  Diversity in the Major Polysaccharide Antigen of Acinetobacter Baumannii Assessed by DNA Sequencing, and Development of a Molecular Serotyping Scheme , 2013, PloS one.

[27]  T. Schäffer,et al.  Structural insight into the giant Ca²⁺-binding adhesin SiiE: implications for the adhesion of Salmonella enterica to polarized epithelial cells. , 2013, Structure.

[28]  K. Suziedelis,et al.  Spread of carbapenem-resistant Acinetobacter baumannii carrying a plasmid with two genes encoding OXA-72 carbapenemase in Lithuanian hospitals. , 2013, The Journal of antimicrobial chemotherapy.

[29]  G. Bodelón,et al.  Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies. , 2013, FEMS microbiology reviews.

[30]  Nicole R. Luke-Marshall,et al.  The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization , 2013, Infection and Immunity.

[31]  M. Iacono,et al.  The genomics of Acinetobacter baumannii: Insights into genome plasticity, antimicrobial resistance and pathogenicity , 2011, IUBMB life.

[32]  G. Pier,et al.  Poly-N-Acetyl-β-(1-6)-Glucosamine Is a Target for Protective Immunity against Acinetobacter baumannii Infections , 2011, Infection and Immunity.

[33]  Evan S Snitkin,et al.  Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii , 2011, Proceedings of the National Academy of Sciences.

[34]  M. McConnell,et al.  Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. , 2010, Vaccine.

[35]  N. Prasadarao,et al.  Deciphering the Roles of Outer Membrane Protein A Extracellular Loops in the Pathogenesis of Escherichia coli K1 Meningitis* , 2010, The Journal of Biological Chemistry.

[36]  I. Linhartova,et al.  RTX proteins: a highly diverse family secreted by a common mechanism , 2010, FEMS microbiology reviews.

[37]  T. Umland,et al.  The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor , 2010, Infection and Immunity.

[38]  Yung-Fu Chang,et al.  The Terminal Immunoglobulin-Like Repeats of LigA and LigB of Leptospira Enhance Their Binding to Gelatin Binding Domain of Fibronectin and Host Cells , 2010, PloS one.

[39]  P. Nordmann,et al.  VIM-19, a Metallo-β-Lactamase with Increased Carbapenemase Activity from Escherichia coli and Klebsiella pneumoniae , 2009, Antimicrobial Agents and Chemotherapy.

[40]  A. Campagnari,et al.  Identification and Characterization of an Acinetobacter baumannii Biofilm-Associated Protein , 2007, Journal of bacteriology.

[41]  Stephen G. J. Smith,et al.  A molecular Swiss army knife: OmpA structure, function and expression. , 2007, FEMS microbiology letters.

[42]  M. Imperiale,et al.  Cytokine Response and Survival of Mice Immunized with an Adenovirus Expressing Bacillus anthracis Protective Antigen Domain 4 , 2006, Infection and Immunity.

[43]  E. Bullitt,et al.  Bacterial Adhesion Pili. , 2018, Sub-cellular biochemistry.

[44]  Medhat A. Haroun,et al.  Development of immunization trials against Acinetobacter baumannii , 2016 .

[45]  G. Patel,et al.  Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice. , 2015, Vaccine.

[46]  S. Pournaras,et al.  Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. , 2013, International journal of antimicrobial agents.